QIAGEN and BioHelix Enter Into Licensing Agreement
Helicase-dependent isothermal DNA amplification system provides new assay technology capabilities for QIAGEN's assay automation platforms
05-May-2008 -
QIAGEN and privately held BioHelix have announced that they have entered into a non-exclusive worldwide license and supply agreement for BioHelix's proprietary Helicase Dependent Amplification technology (HDA). HDA is a versatile assay technology to detect and analyze biological target molecules ...
DNA diagnostic
molecular diagnostics
PCR
+2